QDEL Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: February 23, 2026
Report Source: 2025 Annual Report
QuidelOrtho Corp. Stock Analysis QDEL
QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,500 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
Read More QuidelOrtho Corp (QDEL) Chart
Key Statistics of QuidelOrtho Corp (QDEL)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$11.39Volume
2.45MP/E Ratio (TTM)
-52 Week Range
Market Cap
793.83MAvg. Volume
3.05MDividend Yield
-Financial Metrics & Statements of QuidelOrtho Corp (QDEL)
FAQ's for QuidelOrtho Corp (QDEL)
- According to Musaffa’s Shariah screening methodology, QuidelOrtho Corp (QDEL) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.